Energy Peptides – Cellular & Mitochondrial Research

Mechanisms

Cellular energy versus stimulant energy

This distinction defines the category. Stimulants act on the central nervous system to mask fatigue; the compounds here are studied at the level of the mitochondrion, where ATP is actually produced. That is why MOTS-C is described in research contexts as non-stimulant energy support and is often studied with morning or pre-activity timing, and why endpoints are typically endurance, metabolic efficiency and fatigue recovery rather than immediate alertness.

Purist Peptides research compounds in a laboratory setting

Study design

How the two compounds differ mechanistically

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme required by the electron transport chain — without adequate availability, ATP production is rate-limited, and availability declines with age. It is researched at 25–100 mg, 3–5× weekly for energy and fatigue endpoints. MOTS-C is a peptide encoded in mitochondrial DNA that signals through AMPK to influence metabolic efficiency, insulin sensitivity and fat oxidation; energy and endurance protocols typically run 5 mg, 2–3× weekly over 4–6 weeks. One supplies the substrate, the other tunes the system — which is why they are studied together as often as separately.

The range

Compounds in this category

The compounds grouped here, each with the pathway it is studied for and the protocol shape most often used.

NAD+ research peptide vial by Purist Peptides

NAD+

Cellular coenzyme

An essential coenzyme central to ATP production, DNA repair and sirtuin signalling. Published third-party test report available (1000 mg). Energy and fatigue-recovery protocols run 25–50 mg, 2–3× weekly over 4–6 weeks; cognitive and neuro-energy models extend to 75 mg

View NAD+

MOTS-C

Mitochondrial / AMPK

A mitochondrial-derived peptide studied for AMPK activation, cellular ATP production and muscular efficiency. Published test report available (40 mg).

Energy and endurance protocols run 5 mg, 2–3× weekly over 4–6 weeks, typically timed to morning or pre-activity

View MOTS-C

Selection

How to choose

Start from the research question, not the compound name.

If the research question is…	Start with
Fatigue recovery and cognitive energy endpoints	NAD+
Endurance, performance and metabolic efficiency	MOTS-C
Both pathways in one protocol	the Cellular Longevity Stack pairs them
Broader ageing context	Anti-Aging & Longevity
Metabolic and body-composition endpoints	Peptides for Fat Loss

Pre-paired

Stacks built on this category

Complete research cycles — every vial needed for the full protocol, 10% below buying the vials separately.

Cellular Longevity StackNAD+ + MOTS-C — complete 4-week cycle, 3 vials.View the stack

Independent laboratory testing of Purist Peptides research compounds

Verified quality

Tested before it ships

Published third-party test reports for NAD+ (1000 mg) and MOTS-C (40 mg) · minimum 99% verified purity · full reconstitution volumes, concentration calculations and syringe measurement guides on each product page · lyophilised, refrigerate 2–8 °C after reconstitution. See Quality Standards.

MOTS-C 10 mg99.11% · COA PDF

See Quality Standards & all COAs

Questions

Energy research FAQ

How do NAD+ and MOTS-C differ?

NAD+ is a coenzyme the electron transport chain requires to produce ATP; its availability declines with age. MOTS-C is a mitochondrially encoded peptide that signals through AMPK to influence metabolic efficiency. One supplies a required substrate, the other modulates the pathway.

Are these stimulants?

No. Both are studied at the mitochondrial level rather than through central nervous system stimulation, which is why MOTS-C is characterised in research as non-stimulant energy support. Endpoints are endurance, metabolic efficiency and fatigue recovery rather than acute alertness.

When are these administered in research protocols?

MOTS-C energy protocols commonly use morning or pre-activity timing. NAD+ is dosed 3–5× weekly without a strict timing requirement. Full protocol detail is on each product page.

Can NAD+ and MOTS-C be studied together?

Yes — they address the substrate and signalling sides of the same system, so they are frequently paired. The Cellular Longevity Stack combines both.

How is purity verified?

Both compounds have published third-party test reports (NAD+ 1000 mg, MOTS-C 40 mg), and every batch is independently assayed to a minimum of 99% purity, with certificates on each product page.

Keep exploring